Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 12 studies | 23% ± 6% | |
fibroblast | 11 studies | 20% ± 3% | |
adipocyte | 5 studies | 28% ± 5% | |
smooth muscle cell | 3 studies | 17% ± 1% | |
myofibroblast cell | 3 studies | 21% ± 2% | |
GABAergic neuron | 3 studies | 23% ± 6% | |
glutamatergic neuron | 3 studies | 29% ± 3% | |
astrocyte | 3 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 7637.28 | 652 / 653 | 98% | 66.88 | 591 / 605 |
adrenal gland | 100% | 10234.91 | 258 / 258 | 93% | 20.94 | 213 / 230 |
prostate | 99% | 4088.32 | 243 / 245 | 86% | 8.72 | 432 / 502 |
brain | 87% | 1162.66 | 2288 / 2642 | 97% | 9.67 | 686 / 705 |
breast | 100% | 3226.83 | 458 / 459 | 79% | 7.55 | 881 / 1118 |
kidney | 89% | 1332.02 | 79 / 89 | 81% | 12.86 | 731 / 901 |
lung | 100% | 3519.42 | 577 / 578 | 66% | 5.57 | 762 / 1155 |
bladder | 100% | 3934.90 | 21 / 21 | 39% | 2.56 | 196 / 504 |
ovary | 100% | 7441.21 | 180 / 180 | 38% | 2.73 | 162 / 430 |
esophagus | 90% | 1965.70 | 1307 / 1445 | 47% | 3.47 | 86 / 183 |
uterus | 100% | 3335.66 | 170 / 170 | 37% | 4.24 | 171 / 459 |
intestine | 92% | 2069.17 | 887 / 966 | 37% | 2.76 | 195 / 527 |
skin | 92% | 1560.62 | 1664 / 1809 | 27% | 2.45 | 128 / 472 |
stomach | 60% | 1461.01 | 217 / 359 | 50% | 3.99 | 143 / 286 |
adipose | 100% | 3954.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5353.90 | 1335 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2525.09 | 852 / 861 | 0% | 0 | 0 / 0 |
pancreas | 4% | 39.16 | 13 / 328 | 84% | 8.90 | 150 / 178 |
liver | 21% | 162.38 | 47 / 226 | 57% | 5.01 | 233 / 406 |
tonsil | 0% | 0 | 0 / 0 | 58% | 6.80 | 26 / 45 |
spleen | 54% | 485.16 | 129 / 241 | 0% | 0 | 0 / 0 |
muscle | 53% | 496.25 | 426 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 2.78 | 6 / 29 |
eye | 0% | 0 | 0 / 0 | 4% | 0.16 | 3 / 80 |
peripheral blood | 0% | 1.74 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097601 | Biological process | retina blood vessel maintenance |
GO_0042311 | Biological process | vasodilation |
GO_0043542 | Biological process | endothelial cell migration |
GO_0001935 | Biological process | endothelial cell proliferation |
GO_0061298 | Biological process | retina vasculature development in camera-type eye |
GO_0002040 | Biological process | sprouting angiogenesis |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | VSTM4 |
Protein name | V-set and transmembrane domain-containing protein 4 [Cleaved into: Peptide Lv] |
Synonyms | C10orf72 |
Description | FUNCTION: Peptide Lv enhances L-type voltage-gated calcium channel (L-VGCC) currents in retinal photoreceptors. . |
Accessions | ENST00000332853.9 [Q8IW00-1] Q8IW00 ENST00000298454.3 [Q8IW00-2] |